X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Given Average Recommendation of "Hold" by Brokerages
Shares of X4 Pharmaceuticals, Inc. (NASDAQ:XFOR - Get Free Report) have earned a consensus rating of "Hold" from the five ratings firms that are covering the stock, Marketbeat reports. One investment...